[Experimental and clinical study of Vasosan P, a new form of pectin-enriched cholestyramine]. / Eksperimental'noe i klinicheskoe izuchenie vasozana P--novoi formy kholestiramina, obogashchennogo pektinom.

The bile acid sequestering agent Vasosan P is a new form of pectin-enriched cholestyramine (20%), saccharose (5%) and sorbic acid (0.18%). In comparison with cholestyramine Vasosan P has a more marked hypolipidemic effect in experiment. Vasosan P is remarkable for good organoleptic properties. It is effective in treating patients with type IIa hyperlipoproteinemia and practically has no side effects as cholestyramine.